| Epigenetics in depression and gut-brain axis: A molecular crosstalk N Begum, A Mandhare, KP Tryphena, S Srivastava, MF Shaikh, SB Singh, ... Frontiers in Aging Neuroscience 14, 1048333, 2022 | 33 | 2022 |
| Proteostasis in Parkinson's disease: Recent development and possible implication in diagnosis and therapeutics A Kulkarni, K Preeti, KP Tryphena, S Srivastava, SB Singh, DK Khatri Ageing Research Reviews 84, 101816, 2023 | 26 | 2023 |
| Inter and intracellular mitochondrial transfer: Future of mitochondrial transplant therapy in Parkinson’s disease R Jain, N Begum, KP Tryphena, SB Singh, S Srivastava, SN Rai, ... Biomedicine & pharmacotherapy 159, 114268, 2023 | 25 | 2023 |
| Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson's disease S Rajan, KP Tryphena, S Khan, L Vora, S Srivastava, SB Singh, DK Khatri Ageing Research Reviews, 101915, 2023 | 19 | 2023 |
| NLRP3 inflammasomes: a potential target to improve mitochondrial biogenesis in parkinson's disease M Khot, A Sood, KP Tryphena, S Khan, S Srivastava, SB Singh, DK Khatri European Journal of Pharmacology 934, 175300, 2022 | 19 | 2022 |
| CRISPR/Cas9 genome editing for tissue‐specific in vivo targeting: nanomaterials and translational perspective DK Sahel, LK Vora, A Saraswat, S Sharma, J Monpara, AA D'Souza, ... Advanced Science 10 (19), 2207512, 2023 | 18 | 2023 |
| CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease P Pinjala, KP Tryphena, R Prasad, DK Khatri, W Sun, SB Singh, ... Biomaterials Research 27 (1), 46, 2023 | 16 | 2023 |
| Understanding the involvement of microRNAs in mitochondrial dysfunction and their role as potential biomarkers and therapeutic targets in Parkinson’s disease KP Tryphena, U Anuradha, R Kumar, S Rajan, S Srivastava, SB Singh, ... Journal of Alzheimer's Disease, 1-16, 2022 | 16 | 2022 |
| Integration of miRNA’s theranostic potential with nanotechnology: promises and challenges for Parkinson’s disease therapeutics KP Tryphena, G Singh, N Jain, P Famta, S Srivastava, SB Singh, ... Mechanisms of Ageing and Development 211, 111800, 2023 | 14 | 2023 |
| Mitochondrial complex I as a pathologic and therapeutic target for Parkinson’s disease KP Tryphena, US Nikhil, P Pinjala, S Srivastava, SB Singh, DK Khatri ACS Chemical Neuroscience 14 (8), 1356-1368, 2023 | 14 | 2023 |
| Microtubule acetylation dyshomeostasis in Parkinson’s disease P Naren, KS Samim, KP Tryphena, LK Vora, S Srivastava, SB Singh, ... Translational Neurodegeneration 12 (1), 20, 2023 | 12 | 2023 |
| Dimethyl fumarate ameliorates parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2/Cathepsin D axis M Khot, A Sood, KP Tryphena, P Pinjala, S Srivastava, SB Singh, ... Brain Research 1815, 148462, 2023 | 8 | 2023 |
| Involvement of miRNA on epigenetics landscape of Parkinson's disease: From pathogenesis to therapeutics SN Uppala, KP Tryphena, P Naren, S Srivastava, SB Singh, DK Khatri Mechanisms of Ageing and Development 213, 111826, 2023 | 6 | 2023 |
| Role of F-actin-mediated endocytosis and exercise in mitochondrial transplantation in an experimental Parkinson's disease mouse model R Jain, N Begum, S Rajan, KP Tryphena, DK Khatri Mitochondrion 74, 101824, 2024 | 5 | 2024 |
| High mobility group box 1 cytokine targeted topical delivery of resveratrol embedded nanoemulgel for the management of atopic dermatitis S Nene, G Devabattula, G Vambhurkar, KP Tryphena, PK Singh, ... Drug Delivery and Translational Research, 1-24, 2024 | 2 | 2024 |
| Acute and sub-acute dermal toxicity of meloxicam emulgel: Analysis of biochemical, hematological, histopathological and immunohistochemical expression VGSS Jyothi, H Veerabomma, KP Tryphena, DK Khatri, SB Singh, ... Biochemical and Biophysical Research Communications 660, 88-95, 2023 | 2 | 2023 |
| Revamping the corneal permeability and antiglaucoma therapeutic potential of brinzolamide using transniosomes: optimization, in vitro and preclinical evaluation RK Patil, V Srivastava, R Bhawale, KP Tryphena, DK Khatri, N Doijad, ... Nanomedicine, 2024 | 1 | 2024 |
| Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson's disease S Rajan, A Sood, R Jain, PT Kamatham, DK Khatri Neuroscience Letters 820, 137596, 2024 | 1 | 2024 |
| Neuroprotective role of Carvacrol via Nrf2/HO-1/NLRP3 axis in Rotenone-induced PD mice model S Shah, KP Tryphena, G Singh, A Kulkarni, P Pinjala, DK Khatri Brain Research 1836, 148954, 2024 | | 2024 |
| Evaluation of preclinical efficacy of apremilast-loaded liquid crystalline nanoparticulate gel in amelioration of atopic dermatitis S Nene, G Vambhurkar, KP Tryphena, PK Singh, DK Khatri, S Srivastava Journal of Drug Delivery Science and Technology 96, 105653, 2024 | | 2024 |
